dihexa human clinical trials or studies fda approval status 2026 trial dihexa SCOPE 2026, Simplified Patient Recruitment Management, AI Powered Clinical Trial Finders Dihexa Peptide dihexa clinical trials or human

Each vial contains 5mg of high-purity lyophilized BPC-157 peptide intended exclusively for laboratory research after appropriate reconstitution

No QT prolongation, no arrhythmia signal in published Phase 2/3 data

In that context, NAD IV therapy should be planned around the full medication list, current energy levels, and provider guidance rather than treated as a default add-on

Note that while elevated homocysteine is associated with an increased risk of Alzheimer's disease, systematic reviews of clinical trials comparing vitamin B12 supplementation to placebo groups have not shown a significant effect in preventing or slowing Alzheimer's disease or cognitive decline

Open the full calculator page